A456070 logo

ENCell Co., Ltd. Stock Price

KOSDAQ:A456070 Community·₩79.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A456070 Share Price Performance

₩7,220.00
-5140.00 (-41.59%)
₩7,220.00
-5140.00 (-41.59%)
Price ₩7,220.00

A456070 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks
1 Reward

ENCell Co., Ltd. Key Details

₩4.5b

Revenue

₩6.8b

Cost of Revenue

-₩2.3b

Gross Profit

₩14.4b

Other Expenses

-₩16.7b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-1.52k
-50.95%
-373.72%
26.4%
View Full Analysis

About A456070

Founded
2018
Employees
n/a
CEO
Jongwook Jang
WebsiteView website
encellinc.com

ENCell Co., Ltd. develops cell/gene-based biopharmaceutical products in South Korea. The company develops EN00, an allogeneic umbilical cord-derived mesenchymal stem cell treatment for Charcot-Marie-Tooth disease. It also provides contracting development and manufacturing services for biopharmaceutical products. The company was founded in 2018 and is based in Seoul, South Korea.

Recent A456070 News & Updates

Recent updates

No updates